158 related articles for article (PubMed ID: 21831963)
21. Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers.
Chung FF; Mai CW; Ng PY; Leong CO
Curr Cancer Drug Targets; 2016; 16(1):71-8. PubMed ID: 26563883
[TBL] [Abstract][Full Text] [Related]
22. The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer - a pilot study.
Edler D; Stenstedt K; Ohrling K; Hallström M; Karlgren M; Ingelman-Sundberg M; Ragnhammar P
Eur J Cancer; 2009 Mar; 45(4):705-12. PubMed ID: 19118998
[TBL] [Abstract][Full Text] [Related]
23. Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles.
Hutchinson I; Chua MS; Browne HL; Trapani V; Bradshaw TD; Westwell AD; Stevens MF
J Med Chem; 2001 Apr; 44(9):1446-55. PubMed ID: 11311068
[TBL] [Abstract][Full Text] [Related]
24. In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles.
Leong CO; Suggitt M; Swaine DJ; Bibby MC; Stevens MF; Bradshaw TD
Mol Cancer Ther; 2004 Dec; 3(12):1565-75. PubMed ID: 15634650
[TBL] [Abstract][Full Text] [Related]
25. Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo.
Leong CO; Gaskell M; Martin EA; Heydon RT; Farmer PB; Bibby MC; Cooper PA; Double JA; Bradshaw TD; Stevens MF
Br J Cancer; 2003 Feb; 88(3):470-7. PubMed ID: 12569393
[TBL] [Abstract][Full Text] [Related]
26. The expression of CYP2W1 in colorectal primary tumors, corresponding lymph node metastases and liver metastases.
Stenstedt K; Hallstrom M; Lédel F; Ragnhammar P; Ingelman-Sundberg M; Johansson I; Edler D
Acta Oncol; 2014 Jul; 53(7):885-91. PubMed ID: 24625228
[TBL] [Abstract][Full Text] [Related]
27. Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1.
Nishida CR; Lee M; de Montellano PR
Mol Pharmacol; 2010 Sep; 78(3):497-502. PubMed ID: 20566689
[TBL] [Abstract][Full Text] [Related]
28. CYP2W1 polymorphism: functional aspects and relation to risk for colorectal cancer.
Stenstedt K; Travica S; Guo J; Barragan I; Pors K; Patterson L; Edler D; Mkrtchian S; Johansson I; Ingelman-Sundberg M
Pharmacogenomics; 2013 Oct; 14(13):1615-22. PubMed ID: 24088132
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648).
Aiello S; Wells G; Stone EL; Kadri H; Bazzi R; Bell DR; Stevens MF; Matthews CS; Bradshaw TD; Westwell AD
J Med Chem; 2008 Aug; 51(16):5135-9. PubMed ID: 18666770
[TBL] [Abstract][Full Text] [Related]
30. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
[TBL] [Abstract][Full Text] [Related]
31. The experimental antitumor agents Phortress and doxorubicin are equiactive against human-derived breast carcinoma xenograft models.
Fichtner I; Monks A; Hose C; Stevens MF; Bradshaw TD
Breast Cancer Res Treat; 2004 Sep; 87(1):97-107. PubMed ID: 15377855
[TBL] [Abstract][Full Text] [Related]
32. Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles.
Bradshaw TD; Bibby MC; Double JA; Fichtner I; Cooper PA; Alley MC; Donohue S; Stinson SF; Tomaszewjski JE; Sausville EA; Stevens MF
Mol Cancer Ther; 2002 Feb; 1(4):239-46. PubMed ID: 12467219
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445).
Bradshaw TD; Chua MS; Orr S; Matthews CS; Stevens MF
Br J Cancer; 2000 Jul; 83(2):270-7. PubMed ID: 10901382
[TBL] [Abstract][Full Text] [Related]
34. Preparation and application of anti-peptide antibodies for detection of orphan cytochromes P450.
Hodek P; Hrdinova J; Macova I; Soucek P; Mrizova I; Burdova K; Kizek R; Hudecek J; Stiborova M
Neuro Endocrinol Lett; 2015; 36 Suppl 1():38-45. PubMed ID: 26757124
[TBL] [Abstract][Full Text] [Related]
35. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the induction of DNA strand breaks and poly(ADP-ribose) polymerase-1 activation by 17beta-estradiol in human breast carcinoma cells through alteration of CYP1A1 and CYP1B1 expression.
Lin PH; Lin CH; Huang CC; Fang JP; Chuang MC
Chem Res Toxicol; 2008 Jul; 21(7):1337-47. PubMed ID: 18558727
[TBL] [Abstract][Full Text] [Related]
36. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
Angus WG; Larsen MC; Jefcoate CR
Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
[TBL] [Abstract][Full Text] [Related]
37. Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery.
Stone EL; Citossi F; Singh R; Kaur B; Gaskell M; Farmer PB; Monks A; Hose C; Stevens MF; Leong CO; Stocks M; Kellam B; Marlow M; Bradshaw TD
Bioorg Med Chem; 2015 Nov; 23(21):6891-9. PubMed ID: 26474663
[TBL] [Abstract][Full Text] [Related]
38. Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxins.
Travica S; Pors K; Loadman PM; Shnyder SD; Johansson I; Alandas MN; Sheldrake HM; Mkrtchian S; Patterson LH; Ingelman-Sundberg M
Clin Cancer Res; 2013 Jun; 19(11):2952-61. PubMed ID: 23589180
[TBL] [Abstract][Full Text] [Related]
39. The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cells.
Brantley E; Patel V; Stinson SF; Trapani V; Hose CD; Ciolino HP; Yeh GC; Gutkind JS; Sausville EA; Loaiza-Pérez AI
Anticancer Drugs; 2005 Feb; 16(2):137-43. PubMed ID: 15655410
[TBL] [Abstract][Full Text] [Related]
40. Re-engineering of the duocarmycin structural architecture enables bioprecursor development targeting CYP1A1 and CYP2W1 for biological activity.
Sheldrake HM; Travica S; Johansson I; Loadman PM; Sutherland M; Elsalem L; Illingworth N; Cresswell AJ; Reuillon T; Shnyder SD; Mkrtchian S; Searcey M; Ingelman-Sundberg M; Patterson LH; Pors K
J Med Chem; 2013 Aug; 56(15):6273-7. PubMed ID: 23844629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
